Lionsgate Studios Emerges as Prime M&A Target Amid Content Library Undervaluation

Key Facts

1Lionsgate Studios (LION) trades at less than 10x TTM library EBITDA.

2Liberty Strategic Capital and MHR hold strategic stakes, with a poison pill in place to manage acquisition interest.

3A 12x multiple on the content library implies a value of over $13 per share.

Lionsgate Studios (LION) is increasingly viewed as a top acquisition candidate in the media sector due to its undervalued content library and strategic assets. Currently, the company trades at less than 10 times its trailing twelve-month library EBITDA, suggesting a significant discount relative to its peers. Strategic investors, including Liberty Strategic Capital and MHR Fund Management, have already secured substantial stakes in the firm, highlighting its market appeal. Analysts suggest that applying a 12x multiple to the content library could push the share value above $13. To manage potential bidding wars or hostile takeovers, the company has implemented a "poison pill" shareholder rights plan. As industry consolidation continues, Lionsgate's unique positioning makes it a compelling target for major media players seeking to expand their portfolios.